NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

SLP

Simulations Plus Inc

Jun 30 • 04:00PM ET

17.45

Dollar change +0.59
Percentage change 3.50	%

Healthcare • Health Information Services • USA • NASD

Peers: VRTX REGN GILD AMGN ACAD BIIB BMRN ALKS NBIX SRPT

| Held by: VTI IJR VXF IWM VTWO IWO SPSM VIOO VHT IJT

Scroll to Statements

Index	RUT	P/E	48.84	EPS (ttm)	0.36	Insider Own	19.23%	Shs Outstand	20.11M	Perf Week	2.23%
Market Cap	350.94M	Forward P/E	16.33	EPS next Y	1.07	Insider Trans	-3.01%	Shs Float	16.24M	Perf Month	-45.76%
Enterprise Value	330.35M	PEG	1.39	EPS next Q	0.23	Inst Own	82.52%	Short Float	11.42%	Perf Quarter	-28.16%
Income	7.26M	P/S	4.47	EPS this Y	77.90%	Inst Trans	6.59%	Short Ratio	4.28	Perf Half Y	-38.45%
Sales	78.56M	P/B	1.85	EPS next Y	13.31%	ROA	3.67%	Short Interest	1.85M	Perf YTD	-37.43%
Book/sh	9.43	P/C	16.41	EPS next 5Y	35.21%	ROE	3.96%	52W High	49.71 -64.90%	Perf Year	-63.42%
Cash/sh	1.06	P/FCF	30.62	EPS past 3/5Y	1.30% 0.62%	ROIC	3.82%	52W Low	16.72 4.37%	Perf 3Y	-64.17%
Dividend Est.	-	EV/EBITDA	27.60	Sales past 3/5Y	14.64% 15.56%	Gross Margin	55.28%	Volatility	3.89% 6.36%	Perf 5Y	-70.20%
Dividend TTM	0.06 (0.34%)	EV/Sales	4.21	EPS Y/Y TTM	-31.98%	Oper. Margin	5.05%	ATR (14)	1.32	Perf 10Y	184.20%
Dividend Ex-Date	Jul 29, 2024	Quick Ratio	4.37	Sales Y/Y TTM	21.49%	Profit Margin	9.24%	RSI (14)	23.12	Recom	1.33
Dividend Gr. 3/5Y	0.00% 0.00%	Current Ratio	4.37	EPS Q/Q	-23.55%	SMA20	-19.35%	Beta	0.85	Target Price	36.25
Payout	48.95%	Debt/Eq	0.00	Sales Q/Q	22.55%	SMA50	-38.05%	Rel Volume	1.38	Prev Close	16.86
Employees	247	LT Debt/Eq	0.00	Earnings	Jul 14 AMC	SMA200	-41.33%	Avg Volume	433.46K	Price	17.45
IPO	Jun 18, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.65% 2.30%	Trades		Volume	596,728	Change	3.50%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-15-24	Initiated	Stephens	Overweight	$39
Jul-29-24	Initiated	KeyBanc Capital Markets	Overweight	$47
Jul-16-24	Initiated	JMP Securities	Mkt Perform
Jun-28-24	Initiated	William Blair	Outperform
May-09-23	Initiated	BTIG Research	Buy	$55
Oct-26-21	Upgrade	Craig Hallum	Hold → Buy	$65 → $53
Jan-12-21	Downgrade	Craig Hallum	Buy → Hold
Oct-16-20	Initiated	Raymond James	Outperform	$95
Sep-08-20	Initiated	Oppenheimer	Outperform	$79
Jan-06-20	Initiated	Craig Hallum	Buy	$40

Jun-18-25 04:05PM	Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call (Business Wire)
Jun-17-25 07:58AM	52-Week Lows? No Problem for 3 Stocks With Big Upside Potential (MarketBeat)
Jun-14-25 08:45AM	Simulations Plus price target lowered to $36 from $45 at Craig-Hallum (TipRanks)
Jun-12-25 10:18AM	SLP Cuts FY25 Revenue Outlook, Begins Strategic Reorganization (Zacks) -24.17%
07:50AM	Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum (Business Wire)
04:30PM	Loading…
Jun-11-25 04:30PM	Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue (Business Wire)
Jun-05-25 05:20PM	Rubrik, Inc. (RBRK) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:50AM	Simulations Plus Releases ADMET Predictor 13 (Business Wire)
Jun-03-25 10:30AM	Credo Technology's Q4 Earnings and Sales Beat Estimates, Rise Y/Y (Zacks) +6.33%
May-21-25 10:02AM	Nebius' Q1 Loss Widens Y/Y, Revenues Rise on Strong Core AI Growth (Zacks)
May-19-25 08:26AM	SLP Advances Predictive Toxicology With DILIsym 11: Shares to Benefit? (Zacks)
May-15-25 07:50AM	Simulations Plus Releases DILIsym 11 (Business Wire)
May-02-25 09:40AM	Dolby Q2 Earnings Beat Estimates, Revenue Miss, Stock Down (Zacks)
May-01-25 09:44AM	Blackbaud's Q1 Earnings Beat Estimates & Rise Y/Y, Revenues Down (Zacks)
09:38AM	ANSYS Q1 Earnings & Revenues Miss Estimates, Increase Y/Y, Stock Falls (Zacks)
08:48AM	Loading…
Apr-29-25 08:48AM	Cadence's Q1 Earnings & Revenues Surpass Estimates, Surge Y/Y (Zacks)
Apr-23-25 10:24AM	SAP's Q1 Earnings & Revenues Up Y/Y on Cloud Demand, Stock Up (Zacks)
07:27AM	Iridium's Q1 Earnings & Revenues Top, Increase Y/Y, Shares Tumble (Zacks)
06:01AM	2 Strong Buy Stocks That Are Crashing the Market in April (TipRanks)
Apr-21-25 07:50AM	Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies (Business Wire)
05:42AM	Badger Meter Q1 Earnings Beat on Solid Revenue Growth, Shares Soar 10% (Zacks)
Apr-16-25 08:30AM	Simulations Plus: Benefiting From FDA Modernization And AI (Seeking Alpha)
Apr-04-25 11:24AM	Simulations Plus: I See Promising Growth, But I'm Staying Neutral (Seeking Alpha) +7.83%
08:44AM	SLP's Q2 Earnings Top, Sales Up Y/Y Despite Industry Headwinds (Zacks)
08:02AM	Q2 2025 Simulations Plus Inc Earnings Call (Thomson Reuters StreetEvents)
03:01AM	Simulations Plus Inc (SLP) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
Apr-03-25 08:44PM	Simulations Plus, Inc. (SLP) Q2 2025 Earnings Call Transcript (Seeking Alpha)
05:20PM	Simulations Plus (SLP) Tops Q2 Earnings and Revenue Estimates (Zacks)
04:17PM	Simulations Plus: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results (Business Wire)
09:04AM	Loading…
Apr-01-25 09:04AM	Simulations Plus Gears Up for Q2 Earnings: What's in the Offing? (Zacks)
Mar-20-25 07:00AM	Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date (Business Wire)
Mar-10-25 07:00AM	Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum (Business Wire)
Feb-04-25 07:30AM	Simulations Plus to Participate in Upcoming Healthcare Investor Conferences (Business Wire)
Jan-22-25 07:50AM	Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus Enhancements (Business Wire)
Jan-13-25 07:13PM	Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024 (Business Wire)
07:50AM	Simulations Plus Supported Development of Every FDA-Approved Drug in 2024 (Business Wire)
Jan-08-25 07:34AM	Q1 2025 Simulations Plus Inc Earnings Call (Thomson Reuters StreetEvents) -7.17%
02:00AM	Simulations Plus Inc (SLP) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... (GuruFocus.com)
Jan-07-25 05:15PM	Simulations Plus (SLP) Lags Q1 Earnings Estimates (Zacks)
04:16PM	Simulations Plus: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:06PM	Simulations Plus Reports First Quarter Fiscal 2025 Financial Results (Business Wire)
Jan-03-25 08:15AM	Simulations Plus (SLP) Fell due to Concerns Over the Funding Environment (Insider Monkey)
Dec-17-24 04:06PM	Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date (Business Wire)
Nov-26-24 09:55AM	Wall Street Analysts Predict a 56.99% Upside in Simulations Plus (SLP): Here's What You Should Know (Zacks)
Nov-22-24 07:15AM	Simulations Plus (SLP) Stock Jumps 8.9%: Will It Continue to Soar? (Zacks)
Nov-19-24 08:30AM	Simulations Plus to Participate in the BTIG Digital Health Forum (Business Wire)
Nov-13-24 08:30AM	Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables (Business Wire)
Nov-08-24 09:55AM	How Much Upside is Left in Simulations Plus (SLP)? Wall Street Analysts Think 77.52% (Zacks)
Nov-06-24 08:30AM	Simulations Plus to Participate in the Stephens Annual Investment Conference (Business Wire) +7.76%
Oct-30-24 08:30AM	Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations (Business Wire)
Oct-24-24 10:52AM	Q4 2024 Simulations Plus Inc Earnings Call (Thomson Reuters StreetEvents) -8.89%
03:10AM	Simulations Plus Inc (SLP) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market ... (GuruFocus.com)
Oct-23-24 06:05PM	Simulations Plus (SLP) Surpasses Q4 Earnings Estimates (Zacks)
05:17PM	Simulations Plus: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:06PM	Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results (Business Wire)
Oct-22-24 08:49AM	Simulations Plus (SLP) Fell Due to EBITDA Below Expectations (Insider Monkey)
Oct-09-24 04:06PM	Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date (Business Wire)
Oct-08-24 08:30AM	Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings (Business Wire)
Oct-01-24 10:28AM	Improve Demand Lifted Simulations Plus (SLP) (Insider Monkey)
Sep-04-24 07:00PM	Insider Sale: Director and 10% Owner Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc ... (GuruFocus.com)
Aug-28-24 08:30AM	Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
Aug-26-24 11:00AM	Simulations Plus (SLP) Restructures Business Unit Post-Acquisitions (Zacks)
Aug-23-24 08:00AM	Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions (Business Wire)
Aug-16-24 02:48AM	Should You Hold Simulations Plus (SLP)? (Insider Monkey)
Aug-09-24 09:23AM	Implied Volatility Surging for Simulations Plus (SLP) Stock Options (Zacks)
Aug-02-24 11:34PM	Insider Sale: Director and 10% Owner Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc ... (GuruFocus.com)
Aug-01-24 08:30AM	Simulations Plus Releases DILIsym X (Business Wire)
Jul-30-24 08:30AM	Simulations Plus Releases ADMET Predictor Version 12 (Business Wire)
Jul-25-24 08:30AM	Simulations Plus to Participate in KeyBancs 25th Annual Technology Leadership Forum (Business Wire)
Jul-20-24 09:25AM	Simulations Plus, Inc. (SLP): One of the Most Profitable Stocks According to Hedge Funds? (Insider Monkey)
Jul-12-24 10:07AM	Simulations Plus (SLP) Ties Up With ICCS for Chemical Safety (Zacks)
Jul-11-24 08:30AM	Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety (Business Wire) +7.44%
Jul-03-24 10:20AM	Simulations Plus (SLP) Q3 Earnings & Revenues Beat Estimates (Zacks) -14.87%
09:29AM	Q3 2024 Simulations Plus Inc Earnings Call (Thomson Reuters StreetEvents)
08:02AM	Simulations Plus, Inc. (NASDAQ:SLP) Q3 2024 Earnings Call Transcript (Insider Monkey)
Jul-02-24 08:52PM	SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q3 2024 (InvestorPlace)
04:16PM	Simulations Plus: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:06PM	Simulations Plus Reports Third Quarter Fiscal 2024 Financial Results (Business Wire)
Jun-25-24 10:00AM	Analysts Estimate Simulations Plus (SLP) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jun-20-24 08:30AM	Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit (Business Wire)
Jun-18-24 08:30AM	Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date (Business Wire)
Jun-14-24 12:00PM	Simulations Plus (SLP) Upgraded to Buy: Here's Why (Zacks)
Jun-13-24 09:10AM	Simulations Plus (SLP) Buys Pro-ficiency Holdings for $100M (Zacks)
Jun-12-24 08:58AM	QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus (Business Wire) +6.92%
08:00AM	Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum (Business Wire)
Jun-04-24 07:00PM	Insider Sale: Director and 10% Owner Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc ... (GuruFocus.com)
May-22-24 08:30AM	Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference (Business Wire)
May-16-24 01:18PM	Simulations Plus (SLP) Launches GPX to Advance PBPK Modeling (Zacks)
May-15-24 07:01PM	Director Daniel Weiner Sells 3,000 Shares of Simulations Plus Inc (SLP) (GuruFocus.com)
08:30AM	Simulations Plus Releases GastroPlus X, The Next Generation PBPK/PBBM Modeling & Simulation Software (Business Wire)
May-08-24 09:15PM	Director Daniel Weiner Sells 3,250 Shares of Simulations Plus Inc (SLP) (GuruFocus.com)
May-03-24 02:28AM	Insider Sale at Simulations Plus Inc (SLP): Director and 10% Owner Walter Woltosz Sells 20,000 ... (GuruFocus.com)
Apr-12-24 01:53PM	New AI Bot Predicts These 7 Stocks Will Mint Millionaires (InvestorPlace)
Apr-08-24 09:06AM	Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA (Zacks)
Apr-04-24 09:27AM	Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript (Insider Monkey) +23.61%
08:30AM	U.S. FDA Renews DILIsym Software Licenses for 7th Year (Business Wire)
06:34AM	Simulations Plus (SLP) Q2 Earnings & Revenues Beat Estimates (Zacks)
06:24AM	Q2 2024 Simulations Plus Inc Earnings Call (Thomson Reuters StreetEvents)
Apr-03-24 08:53PM	SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)

Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Durham, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WOLTOSZ WALTER S	Director	Jun 02 '25	Sale	27.15	20,000	543,074	3,324,157	Jun 03 04:57 PM
WOLTOSZ WALTER S	Director	May 01 '25	Sale	33.51	20,000	670,150	3,344,157	May 01 05:53 PM
WOLTOSZ WALTER S	Director	Apr 01 '25	Sale	24.09	20,000	481,786	3,363,371	Apr 02 04:20 PM
VIRGINIA EVANS WOLTOSZ & WALTE	Director	Apr 01 '25	Proposed Sale	24.52	60,000	1,471,200		Apr 01 04:20 PM
WOLTOSZ WALTER S	Director	Mar 03 '25	Sale	28.68	20,000	573,600	3,383,371	Mar 04 05:08 PM
WOLTOSZ WALTER S	Director	Feb 03 '25	Sale	33.91	20,000	678,243	3,402,584	Feb 04 05:33 PM
WOLTOSZ WALTER S	Director	Jan 02 '25	Sale	27.88	20,000	557,662	3,422,584	Jan 03 04:36 PM
VIRGINIA EVANS WOLTOSZ & WALTE	Director	Jan 02 '25	Proposed Sale	27.89	60,000	1,673,400		Jan 02 04:21 PM
WEINER DANIEL L	Director	Dec 27 '24	Sale	28.50	750	21,375	7,236	Dec 30 04:17 PM
DANIEL LEE WEINER	Director	Dec 27 '24	Proposed Sale	28.78	750	21,585		Dec 27 04:17 PM
WOLTOSZ WALTER S	Director	Dec 02 '24	Sale	31.76	20,000	635,200	3,442,584	Dec 03 05:35 PM
LaVange Lisa	Director	Dec 02 '24	Sale	31.88	650	20,722	7,150	Dec 03 05:32 PM
LISA LAVANGE	Officer	Dec 02 '24	Proposed Sale	31.77	650	20,650		Dec 02 04:34 PM
WOLTOSZ WALTER S	Director	Nov 01 '24	Sale	27.66	20,000	553,200	3,462,584	Nov 05 08:02 AM
WOLTOSZ WALTER S	Director	Oct 01 '24	Sale	31.26	20,000	625,200	3,481,592	Oct 02 04:34 PM
WEINER DANIEL L	Director	Sep 27 '24	Sale	31.54	750	23,655	6,994	Oct 01 04:30 PM
VIRGINIA EVANS WOLTOSZ & WALTE	Director	Oct 01 '24	Proposed Sale	32.02	60,000	1,921,200		Oct 01 04:29 PM
DANIEL LEE WEINER	Director	Sep 27 '24	Proposed Sale	31.07	750	23,302		Sep 27 04:24 PM
BRETT ALYN HOWELL	Officer	Sep 18 '24	Proposed Sale	32.00	12,200	390,400		Sep 18 04:17 PM
Fiedler-Kelly Jill	Business Unit President	Sep 09 '24	Option Exercise	9.71	2,250	21,848	68,867	Sep 10 04:45 PM
WOLTOSZ WALTER S	Director	Sep 03 '24	Sale	35.18	20,000	703,677	3,501,592	Sep 04 04:11 PM
LaVange Lisa	Director	Sep 03 '24	Sale	35.95	650	23,368	6,808	Sep 04 04:09 PM
LISA LAVANGE	Director	Sep 03 '24	Proposed Sale	36.25	650	23,562		Sep 03 04:29 PM
WOLTOSZ WALTER S	Director	Aug 01 '24	Sale	39.63	20,000	792,547	3,521,592	Aug 02 04:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SLP

Simulations Plus Inc

Upgrade your FINVIZ experience